Northwestern Mutual Wealth Management’s Oramed Pharmaceuticals ORMP Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio ORMP Stock Details ORMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.36K	Sell	1,575 -131	-8%	-$444	﹤0.01%	3288
2025 Q4	$4.86K	Buy	1,706 +131	+8%	+$338	﹤0.01%	3238
2025 Q3	$4.16K	Hold	1,575	–	–	﹤0.01%	3202
2025 Q2	$3.54K	Hold	1,575	–	–	﹤0.01%	3110
2025 Q1	$3.37K	Hold	1,575	–	–	﹤0.01%	3037
2024 Q4	$3.81K	Hold	1,575	–	–	﹤0.01%	3020
2024 Q3	$3.84K	Hold	1,575	–	–	﹤0.01%	2973
2024 Q2	$4.05K	Hold	1,575	–	–	﹤0.01%	2921
2024 Q1	$4.6K	Hold	1,575	–	–	﹤0.01%	2866
2023 Q4	$3.64K	Hold	1,575	–	–	﹤0.01%	2952
2023 Q3	$4.11K	Hold	1,575	–	–	﹤0.01%	2803
2023 Q2	$5.64K	Hold	1,575	–	–	﹤0.01%	2744
2023 Q1	$3.43K	Hold	1,575	–	–	﹤0.01%	2848
2022 Q4	$18.9K	Hold	1,575	–	–	﹤0.01%	2268
2022 Q3	$10K	Buy	+1,575	New	+$12.7K	﹤0.01%	2472
2015 Q2	–	Sell	-1,667	Closed	-$11K	–	1567
2015 Q1	$11K	Buy	+1,667	New	+$8.05K	﹤0.01%	1015
2014 Q2	–	Sell	-42	Closed	–	–	1357
2014 Q1	$0	Buy	+42	New	+$709	﹤0.01%	1409

Other funds holding ORMP

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

Aquamarine Financial George Town $1.37B AUM

Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return

GIA

Gem Investment Advisors Teaneck, New Jersey $102M AUM

Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Northwestern Mutual Wealth Management's ORMP Position: Q1 2026 in Review

Northwestern Mutual Wealth Management reduced its Oramed Pharmaceuticals (ORMP) stake by 7.7% in Q1 2026, selling an estimated $444 and leaving 1,575 shares worth $5.36K. The position accounts for ﹤0.01% of the portfolio, ranked #3288.

Northwestern Mutual Wealth Management first reported a position in ORMP in Q1 2014 and has held it in 17 quarters since. The position peaked at $18.9K in Q4 2022. 64 funds tracked by Wall St. Rank hold ORMP as of Q1 2026.

Northwestern Mutual Wealth Management held 1,575 shares of Oramed Pharmaceuticals worth $5.36K as of Q1 2026.
Northwestern Mutual Wealth Management sold 131 Oramed Pharmaceuticals shares in Q1 2026, an estimated $444.
Oramed Pharmaceuticals made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #3288 holding.
Northwestern Mutual Wealth Management first reported a position in Oramed Pharmaceuticals in Q1 2014 and has held it in 17 quarters since.
Northwestern Mutual Wealth Management's Oramed Pharmaceuticals position peaked at $18.9K in Q4 2022.
64 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.